MOLECULAR-TARGETED ADOPTIVE IMMUNE THERAPY FOR ERADICATION OF METASTATIC PROSTATE CANCER

$553,016FY2014Department of DefenseDOD

Virginia Commonwealth University, Richmond VA

Investigators